Hainan Huluwa Pharmaceutical Group Co Ltd Total Assets

Latest as of March 2026: CN¥2.56 Billion CNY ≈ $374.03 Million USD

Hainan Huluwa Pharmaceutical Group Co Ltd total assets. Based on the latest financial reports, Hainan Huluwa Pharmaceutical Group Co Ltd (605199) holds total assets worth CN¥2.56 Billion CNY (≈ $374.03 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Hainan Huluwa Pharmaceutical Group Co Lt (605199) total market value for the company's overall valuation and market capitalisation.

Total Assets of Hainan Huluwa Pharmaceutical Group Co Ltd (2016–2025)

Total assets of Hainan Huluwa Pharmaceutical Group Co Ltd from 2016 to 2025. This chart illustrates how Hainan Huluwa Pharmaceutical Group Co Ltd's total assets have evolved over time, based on quarterly financial data. See latest Hainan Huluwa Pharmaceutical Group Co Lt stock price today for real-time trading data and today's change.

Hainan Huluwa Pharmaceutical Group Co Ltd - Asset Composition Analysis

Hainan Huluwa Pharmaceutical Group Co Ltd Total Assets Breakdown (December 2025)

Hainan Huluwa Pharmaceutical Group Co Ltd total assets breakdown as of December 2025. Hainan Huluwa Pharmaceutical Group Co Ltd's total assets of CN¥2.56 Billion consist of 33.9% current assets and 66.1% non-current assets.

Asset Category	Amount (CNY)	% of Total Assets
Cash & Equivalents	CN¥0.00	3.0%
Accounts Receivable	CN¥418.01 Million	16.1%
Inventory	CN¥254.34 Million	9.8%
Property, Plant & Equipment	CN¥0.00	0.0%
Intangible Assets	CN¥274.49 Million	10.6%
Goodwill	CN¥0.00	0.0%

Asset Composition Trend (2016–2025)

This chart illustrates how Hainan Huluwa Pharmaceutical Group Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Hainan Huluwa Pharmaceutical Group Co Lt working capital to net assets to assess how much short-term liquidity the company maintains relative to its equity base.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Hainan Huluwa Pharmaceutical Group Co Ltd's current assets represent 33.9% of total assets in 2025, a decrease from 41.1% in 2016.
Cash Position: Cash and equivalents constituted 3.0% of total assets in 2025, down from 11.6% in 2016.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 10.0% of total assets, a decrease from 20.0% in 2016.
Asset Diversification: The largest asset category is accounts receivable at 16.1% of total assets.

Hainan Huluwa Pharmaceutical Group Co Ltd Competitors by Total Assets

Key competitors of Hainan Huluwa Pharmaceutical Group Co Ltd based on total assets are shown below.

Company	Country	Total Assets
Takeda Pharmaceutical Company Limited F:TKDA	Germany	€15.41 Trillion
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	USA	$15.42 Trillion
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Germany	€1.60 Trillion
Ajanta Pharma Limited NSE:AJANTPHARM	India	Rs56.72 Billion
Changchun High & New Technology Industries Group Inc SHE:000661	China	CN¥30.77 Billion
Jiangsu Nhwa Pharmaceutical Co Ltd SHE:002262	China	CN¥9.54 Billion
Porton Fine Chemicals Ltd SHE:300363	China	CN¥8.58 Billion
Jubilant Pharmova Limited NSE:JUBLPHARMA	India	Rs135.21 Billion

Hainan Huluwa Pharmaceutical Group Co Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	0.63	0.84	2.22
Quick Ratio	0.46	0.53	1.69
Cash Ratio	0.00	0.00	0.00
Working Capital	CN¥-510.46 Million	CN¥-232.47 Million	CN¥434.27 Million

Hainan Huluwa Pharmaceutical Group Co Ltd - Advanced Valuation Insights

This section examines the relationship between Hainan Huluwa Pharmaceutical Group Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	6.97
Latest Market Cap to Assets Ratio	0.12
Asset Growth Rate (YoY)	-12.2%
Total Assets	CN¥2.60 Billion
Market Capitalization	$313.82 Million USD

Valuation Analysis

Below Book Valuation: The market values Hainan Huluwa Pharmaceutical Group Co Ltd's assets below their book value (0.12x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: Hainan Huluwa Pharmaceutical Group Co Ltd's assets decreased by 12.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Hainan Huluwa Pharmaceutical Group Co Ltd (2016–2025)

The table below shows the annual total assets of Hainan Huluwa Pharmaceutical Group Co Ltd from 2016 to 2025.

Year	Total Assets	Change
2025-12-31	CN¥2.60 Billion ≈ $380.89 Million	-12.20%
2024-12-31	CN¥2.96 Billion ≈ $433.81 Million	-3.14%
2023-12-31	CN¥3.06 Billion ≈ $447.85 Million	+32.37%
2022-12-31	CN¥2.31 Billion ≈ $338.33 Million	+31.30%
2021-12-31	CN¥1.76 Billion ≈ $257.68 Million	+15.76%
2020-12-31	CN¥1.52 Billion ≈ $222.59 Million	+39.99%
2019-12-31	CN¥1.09 Billion ≈ $159.00 Million	-0.49%
2018-12-31	CN¥1.09 Billion ≈ $159.79 Million	+35.28%
2017-12-31	CN¥807.21 Million ≈ $118.12 Million	+50.61%
2016-12-31	CN¥535.95 Million ≈ $78.43 Million	--

About Hainan Huluwa Pharmaceutical Group Co Ltd

SHG:605199 China Drug Manufacturers - Specialty & Generic

Market Cap

$313.82 Million

CN¥2.14 Billion CNY

Market Cap Rank

#14273 Global

#4248 in China

Share Price

CN¥5.36

Change (1 day)

+0.75%

52-Week Range

CN¥5.19 - CN¥10.04

All Time High

CN¥48.21